InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Explore the complete record of transactions filed by Butchko Julia G., Directrice du Développement et de la Technologie. Officer active across 1 companies, notably Immunovant, Inc.. Cumulatively, 8 disclosures have been logged. Total volume traded: €750k. The latest transaction was filed on 29 June 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
€1,770460 shares@ €3.84810.0000% mcap0.2% of flow
Common Stock
SEC:0001764013-22-000071:0·
€1,737492 shares@ €3.530.0000% mcap0.2% of flow
Common Stock
SEC:0001764013-22-000047:0·
€2,419541 shares@ €4.47180.0000% mcap0.3% of flow
Common Stock
SEC:0001764013-22-000043:0·
€34,2066,381 shares@ €5.36060.0006% mcap4.6% of flow
Common Stock
SEC:0001764013-22-000037:0·
€355,01455,318 shares@ €6.41770.0063% mcap47.3% of flow
Common Stock
SEC:0001764013-22-000013:0·
€355,01455,318 shares@ €6.41770.0063% mcap100.0% of flow
Common Stock
SEC:0001764013-22-000013·
0285,306 shares0
Common Stock
SEC:0001764013-21-000069·
0285,306 shares0
Common Stock
SEC:0001764013-21-000069:0·
8 of 8 declarations
About Butchko Julia G.
Julia G. Butchko is the Chief Development & Technology Officer at Immunovant, Inc. She oversees product development initiatives and the company's technology strategies. With significant experience in innovation and development, she is committed to advancing Immunovant's mission. Her expertise is crucial for the company's success.
